Ｍ－グリーンペプタイ：Notice of the initiation of a phase II clinical trial of GRN-1201 with the concomitant use of an immune checkpoint antibody against NSCLC in the U.S. - 有報キャッチャー

Ｍ－グリーンペプタイ（4594）　Notice of the initiation of a phase II clinical trial of GRN-1201 with the concomitant use of an immune checkpoint antibody against NSCLC in the U.S. 2017/01/27

/-

読み込み中…